Ruolan You

481 total citations
21 papers, 328 citations indexed

About

Ruolan You is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Ruolan You has authored 21 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Hematology and 6 papers in Oncology. Recurrent topics in Ruolan You's work include Acute Myeloid Leukemia Research (6 papers), RNA modifications and cancer (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Ruolan You is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), RNA modifications and cancer (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Ruolan You collaborates with scholars based in China, United States and Taiwan. Ruolan You's co-authors include Diyu Hou, Huifang Huang, Jingru Liu, Xiaoting Wang, Ping Chen, Qian Huang, Xiaoting Wang, Bin Wang, Qingfeng Zhai and Bin Wang and has published in prestigious journals such as ACS Nano, Experimental Cell Research and Journal of Cellular Physiology.

In The Last Decade

Ruolan You

19 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruolan You China 9 196 99 68 45 43 21 328
Daniel Wysokiński Poland 12 159 0.8× 51 0.5× 24 0.4× 25 0.6× 51 1.2× 20 346
Zhanhong Hu China 10 168 0.9× 55 0.6× 14 0.2× 16 0.4× 35 0.8× 20 300
Sandra Lettlová Czechia 9 328 1.7× 178 1.8× 34 0.5× 22 0.5× 28 0.7× 11 487
Yiqun Huang China 15 315 1.6× 94 0.9× 47 0.7× 27 0.6× 28 0.7× 42 426
Jinghua Yuan China 10 174 0.9× 35 0.4× 36 0.5× 21 0.5× 56 1.3× 23 284
Yutong Meng China 9 236 1.2× 123 1.2× 8 0.1× 40 0.9× 49 1.1× 13 368
Yong Feng China 11 339 1.7× 218 2.2× 24 0.4× 31 0.7× 71 1.7× 21 503
Yuanxu Guo China 13 222 1.1× 143 1.4× 13 0.2× 41 0.9× 39 0.9× 30 393
Nisha Tapryal United States 11 257 1.3× 47 0.5× 47 0.7× 20 0.4× 50 1.2× 16 392
Aiko Aoki Japan 11 182 0.9× 112 1.1× 9 0.1× 98 2.2× 14 0.3× 16 503

Countries citing papers authored by Ruolan You

Since Specialization
Citations

This map shows the geographic impact of Ruolan You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruolan You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruolan You more than expected).

Fields of papers citing papers by Ruolan You

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruolan You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruolan You. The network helps show where Ruolan You may publish in the future.

Co-authorship network of co-authors of Ruolan You

This figure shows the co-authorship network connecting the top 25 collaborators of Ruolan You. A scholar is included among the top collaborators of Ruolan You based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruolan You. Ruolan You is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Jingru, Ruolan You, Xiaolin Xu, et al.. (2025). Circulating mucosa-associated invariant T cells are decreased and have impaired function in patients with diffuse large B-cell lymphoma. Translational Oncology. 59. 102461–102461. 1 indexed citations
2.
Liu, Yifan, Wei Dai, Baomin Chen, et al.. (2025). RAR-Based Prognostic Model for Predicting Overall Survival in Hepatitis B Virus-Related Hepatocellular Carcinoma: A Multicenter Study. Journal of Inflammation Research. Volume 18. 9159–9170.
4.
Zhang, Changqing, Xiao Li, Shuxian Li, et al.. (2025). Gestational Exposure to Black Phosphorus Nanoparticles Induces Placental Trophoblast Dysfunction by Triggering Reactive Oxygen Species-Regulated Mitophagy. ACS Nano. 19(17). 16517–16533. 1 indexed citations
5.
You, Ruolan, Jin Wang, Wei Dai, et al.. (2024). The Red Cell Distribution Width to Albumin Ratio: A Novel Prognostic Indicator in Hepatitis B Virus-Related Hepatocellular Carcinoma. International Journal of Medical Sciences. 22(2). 441–450. 3 indexed citations
6.
You, Ruolan, Jiaqi Zhou, Chunying Wang, et al.. (2024). Ferroptosis is involved in trophoblast cells cytotoxicity induced by black phosphorus nanoparticles. Toxicology. 505. 153810–153810. 3 indexed citations
7.
Liu, Bang, et al.. (2023). Red Blood Cell Distribution Width as a Potential Valuable Survival Predictor in Hepatitis B Virus-related Hepatocellular Carcinoma. International Journal of Medical Sciences. 20(7). 976–984. 3 indexed citations
8.
Hou, Diyu, et al.. (2023). Interleukin-6 Facilitates Acute Myeloid Leukemia Chemoresistance via Mitofusin 1–Mediated Mitochondrial Fusion. Molecular Cancer Research. 21(12). 1366–1378. 13 indexed citations
9.
Wang, Xiaoting, Jun Huang, Ruolan You, et al.. (2023). Downregulation of ITGA5 inhibits lymphangiogenesis and cell migration and invasion in male laryngeal squamous cell carcinoma. PROTOPLASMA. 260(6). 1569–1580. 1 indexed citations
10.
You, Ruolan, et al.. (2023). HIF-1α is an important regulator of IL-8 expression in human bone marrow stromal cells under hypoxic microenvironment. PROTOPLASMA. 261(3). 543–551. 2 indexed citations
11.
Liu, Jingru, et al.. (2023). Deletion of Mettl3 in mesenchymal stem cells promotes acute myeloid leukemia resistance to chemotherapy. Cell Death and Disease. 14(12). 796–796. 8 indexed citations
13.
Li, Yuxin, Jiamin Li, Ruolan You, et al.. (2023). Combined exposure of beta-cypermethrin and emamectin benzoate interferes with the HPO axis through oxidative stress, causing an imbalance of hormone homeostasis in female rats. Reproductive Toxicology. 123. 108502–108502. 41 indexed citations
14.
Li, Yuxin, et al.. (2022). The combined effect of titanium dioxide nanoparticles and cypermethrin on male reproductive toxicity in rats. Environmental Science and Pollution Research. 30(9). 22176–22187. 16 indexed citations
15.
You, Ruolan, Bin Wang, Ping Chen, et al.. (2022). Metformin sensitizes AML cells to chemotherapy through blocking mitochondrial transfer from stromal cells to AML cells. Cancer Letters. 532. 215582–215582. 35 indexed citations
16.
Chen, Ling, Jingru Liu, Haoran Hu, et al.. (2022). m 6 A RNA methylation regulators predict prognosis and indicate characteristics of tumour microenvironment infiltration in acute myeloid leukaemia. Epigenetics. 18(1). 2160134–2160134. 6 indexed citations
17.
Hou, Diyu, Bin Wang, Ruolan You, et al.. (2020). Stromal cells promote chemoresistance of acute myeloid leukemia cells via activation of the IL-6/STAT3/OXPHOS axis. Annals of Translational Medicine. 8(21). 1346–1346. 41 indexed citations
18.
Wang, Xiaoting, Bin Wang, Shuxia Zhang, et al.. (2019). Melatonin inhibits lung metastasis of gastric cancer in vivo. Biomedicine & Pharmacotherapy. 117. 109018–109018. 30 indexed citations
19.
Chen, Ping, Diyu Hou, Xiaoting Wang, et al.. (2019). Homoharringtonine potentiates the antileukemic activity of arsenic trioxide against acute myeloid leukemia cells. Experimental Cell Research. 376(2). 114–123. 9 indexed citations
20.
Wang, Bin, Xiaoting Wang, Diyu Hou, et al.. (2018). Exosomes derived from acute myeloid leukemia cells promote chemoresistance by enhancing glycolysis‐mediated vascular remodeling. Journal of Cellular Physiology. 234(7). 10602–10614. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026